Clinical trial country use share
RecordSTO-7127B58S5V-KGVEXTVKV9-AJM7SQ
China · 2021–2023
Clinical trial country use share in China was 13% in 2021–2023 (IQVIA).
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Locator
- Country utilization is heavily consolidated in U.S., China and Western European countries
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
The top 10 most used countries account for 58% of the total average pipeline country use, with the United States and China responsible for 16% and 13%, respectively, of total country-uses for trials started in the 2021–2023 timeframe.
Checked: the figure 13% is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IQVIA Institute. (2023). Rethinking Clinical Trial Country Prioritization. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Via StatOrigin, https://statorigin.org/stat/stat_7127B58S5VKGVEXTVKV9AJM7SQ
Other formats: MLA, Chicago, BibTeX
- MLA
- IQVIA Institute. "Rethinking Clinical Trial Country Prioritization." 2023, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_7127B58S5VKGVEXTVKV9AJM7SQ.
- Chicago
- IQVIA Institute. "Rethinking Clinical Trial Country Prioritization." 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_7127B58S5VKGVEXTVKV9AJM7SQ.
- BibTeX
- @misc{iqvia2023clinicalajm7sq, author = {{IQVIA Institute}}, title = {Rethinking Clinical Trial Country Prioritization}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_7127B58S5VKGVEXTVKV9AJM7SQ}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Rethinking Clinical Trial Country Prioritization
- Type
- Press release
- Published
- —
- Locator
- Country utilization is heavily consolidated in U.S., China and Western European countries
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- editorial:judge-fix-v1:2026-09-27
- Checked on
- 27 September 2026
- Last revision
- 27 September 2026
- Permanent URL
- /stat/stat_7127B58S5VKGVEXTVKV9AJM7SQ